157 related articles for article (PubMed ID: 30015780)
21. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.
Borgognone A; Pulcinelli FM
Thromb Haemost; 2012 Nov; 108(5):955-62. PubMed ID: 23014861
[TBL] [Abstract][Full Text] [Related]
22. Expression of regulatory platelet microRNAs in patients with sickle cell disease.
Jain S; Kapetanaki MG; Raghavachari N; Woodhouse K; Yu G; Barge S; Coronnello C; Benos PV; Kato GJ; Kaminski N; Gladwin MT
PLoS One; 2013; 8(4):e60932. PubMed ID: 23593351
[TBL] [Abstract][Full Text] [Related]
23. [Down regulation of multidrug resistance-associated protein 4 expression by RNA interference enhances radiosensitivity of colorectal carcinoma cell lines in vitro].
Yu ZQ; Zhang C; Cai R; Lao XY; Wang H; Gao XH; Han YF; Zhang XQ; Cao GW; Fu CG
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jan; 15(1):67-71. PubMed ID: 22287356
[TBL] [Abstract][Full Text] [Related]
24. Low miR-19b-1-5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio- Cerebrovascular Events in Patients With Acute Coronary Syndrome.
Singh S; de Ronde MWJ; Creemers EE; Van der Made I; Meijering R; Chan MY; Hwee Tan S; Tang Chin C; Mark Richards A; Troughton RW; Yean Yip Fong A; Yan BP; Pinto-Sietsma SJ
J Am Heart Assoc; 2021 Jan; 10(2):e017120. PubMed ID: 33441016
[TBL] [Abstract][Full Text] [Related]
25. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.
Serebruany VL; Malinin AI; Ziai W; Pokov AN; Bhatt DL; Alberts MJ; Hanley DF
Stroke; 2005 Oct; 36(10):2289-92. PubMed ID: 16151033
[TBL] [Abstract][Full Text] [Related]
26. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
27. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
Zheng WD; Zhou FL; Lin N
Genet Mol Res; 2015 Dec; 14(4):16872-9. PubMed ID: 26681033
[TBL] [Abstract][Full Text] [Related]
29. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients.
Mateos-Cáceres PJ; Macaya C; Azcona L; Modrego J; Mahillo E; Bernardo E; Fernandez-Ortiz A; López-Farré AJ
Thromb Haemost; 2010 Jan; 103(1):160-70. PubMed ID: 20062920
[TBL] [Abstract][Full Text] [Related]
30. Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma.
Hu H; Wang Y; Qin Z; Sun W; Chen Y; Wang J; Wang Y; Nie J; Chen L; Cai S; Yu L; Zeng S
Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33946595
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4.
Hoque MT; Cole SP
Cancer Res; 2008 Jun; 68(12):4802-9. PubMed ID: 18559527
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
[TBL] [Abstract][Full Text] [Related]
33. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
34. Association of MicroRNAs and YRNAs With Platelet Function.
Kaudewitz D; Skroblin P; Bender LH; Barwari T; Willeit P; Pechlaner R; Sunderland NP; Willeit K; Morton AC; Armstrong PC; Chan MV; Lu R; Yin X; Gracio F; Dudek K; Langley SR; Zampetaki A; de Rinaldis E; Ye S; Warner TD; Saxena A; Kiechl S; Storey RF; Mayr M
Circ Res; 2016 Feb; 118(3):420-432. PubMed ID: 26646931
[TBL] [Abstract][Full Text] [Related]
35. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
36. Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor-4 (MRP4) as a new antiplatelet therapy.
Mendes-Silverio CB; Lescano CH; Zaminelli T; Sollon C; Anhê GF; Antunes E; Mónica FZ
Biochem Pharmacol; 2018 Jun; 152():165-173. PubMed ID: 29605625
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients.
Luchessi AD; Silbiger VN; Hirata RD; Lima-Neto LG; Cavichioli D; Iñiguez A; Bravo M; Bastos G; Sousa AG; Brión M; Carracedo A; Hirata MH
Clin Chim Acta; 2013 Oct; 425():9-17. PubMed ID: 23832067
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.
Osman A; Fälker K
Platelets; 2011; 22(6):433-41. PubMed ID: 21438667
[TBL] [Abstract][Full Text] [Related]
39. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2.
Jin Q; Li XJ; Cao PG
Tohoku J Exp Med; 2016 Feb; 238(2):143-51. PubMed ID: 26843134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
